Qin Tang is a PhD-level cancer biologist specializing in clinical diagnostics product development. They began their career as a Graduate Student at Massachusetts General Hospital, where they developed innovative zebrafish models for cell transplantation and utilized single-cell RNA-seq techniques. Qin has held roles as a Scientist and Senior Scientist at Foundation Medicine, leading the development of an early cancer detection assay and managing team members. Currently, they work as a Senior Scientist in Research and Development at NeoGenomics Laboratories, focusing on liquid biopsy product development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices